A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia

Title
A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 23, Issue 3, Pages 697-706
Publisher
American Association for Cancer Research (AACR)
Online
2016-08-09
DOI
10.1158/1078-0432.ccr-16-0984

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now